Non Malignant pain Global Clinical Trials Review, H1, 2018

  • ID: 4539034
  • Clinical Trials
  • Region: Global
  • 44 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Crescita Therapeutics Inc
  • DURECT Corp
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Pfizer Inc
  • Shionogi & Co Ltd
  • MORE
Non Malignant pain Global Clinical Trials Review, H1, 2018

Summary

The clinical trial report, “Non Malignant pain Global Clinical Trials Review, H1, 2018" provides an overview of Non Malignant pain clinical trials scenario. This report provides top line data relating to the clinical trials on Non Malignant pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Crescita Therapeutics Inc
  • DURECT Corp
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Pfizer Inc
  • Shionogi & Co Ltd
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Non Malignant pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Non Malignant pain Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Source
List of Tables
  • Non Malignant pain Therapeutics, Global, Clinical Trials by Region, 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Proportion of Non Malignant pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018*
  • Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Non Malignant pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Non Malignant pain Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Non Malignant pain Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Proportion of Non Malignant pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018*
  • Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Non Malignant pain Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Non Malignant pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Non Malignant pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Torrent Pharmaceuticals Ltd
  • Pfizer Inc
  • Mundipharma International Ltd
  • Valeant Pharmaceuticals International Inc
  • Shionogi & Co Ltd
  • GlaxoSmithKline Plc
  • Endo International Plc
  • DURECT Corp
  • Dr. Reddy's Laboratories Ltd
  • Crescita Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll